SoftBank Group Corp. (9984) · RiskMitigated
Regulatory Approval and Closing Risks for the Sale of Boston Dynamics
First written in FY2021-Q3. 1 of 2 entries say "Mitigated", first in FY2022-Q1. Latest entry: FY2022-Q1.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
M&A Competition Law and Regulatory Approval RiskA theme 3 companies write about · 4 as a headwind · 0 as a tailwind
2 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2022-Q1MitigatedAnnual report
「Following regulatory approval and the satisfaction of other requirements, the transaction was completed on 21 June 2021. From that date, Boston Dynamics ceased to be a subsidiary of the Company, and the shares in the company that continue to be held as a minority investment are measured at fair value as financial instruments at FVTPL.」
The closing risk associated with the sale of Boston Dynamics was reduced after the conditions, including regulatory approval, were satisfied and the transaction was completed. - FY2021-Q3First statedAnnual report
「The transaction requires regulatory approval and the satisfaction of other customary closing conditions, and is expected to be completed by June 2021.」
A new transaction risk was disclosed regarding the sale of a majority of Boston Dynamics’ shares, subject to regulatory approval and other conditions, with completion expected by June 2021.